secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001477932-23-001176
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx raises $7.525M in public offering of 4.3M shares plus full over-allotment
--------------------------------------------------------------------------------

- Gross proceeds $7.525M from 4,300,000 shares at $1.75/share; net ~$8.0M after underwriting discount.
- Underwriter exercised option for 645,000 additional shares, bringing total to 4,945,000 shares.
- Proceeds to fund R&D, clinical studies, product commercialization, working capital, and potential acquisitions.
- Preliminary unaudited cash and equivalents of ~$10.9M as of Dec 31, 2022.
- Offering led by Newbridge Securities; closed Feb 22, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793223001176/0001477932-23-001176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793223001176/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-001176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer